Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Aug 7, 2026, 4:00 PM EDT
1.650
-0.010 (-0.60%)
After-hours: Aug 7, 2026, 4:10 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $6.06 million as of August 7, 2026. Its market cap has decreased by -68.74% in one year.
Market Cap
6.06M
Enterprise Value
2.74M
1-Year Change
-68.74%
Ranking
Category
Stock Price
$1.66
ChartMarket Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $6.06M, a decrease of -96.34%. That is a compound annual growth rate of -25.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.06M | -25.56% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 6.50M |
| CollPlant Biotechnologies | 6.41M |
| PharmaCyte Biotech | 6.34M |
| AIM ImmunoTech | 6.30M |
| NuCana | 6.12M |
| Addex Therapeutics | 6.12M |
| Purple Biotech | 6.10M |
| Soligenix | 5.81M |